Angiogenesis is a critical protective mechanism for neuroregeneration after stroke, and stem cell therapies promote it primarily through the bystander effect by secreting growth factors (e.g., VEGF, BDNF, IGF‐1, Ang‐1) [719, 720, 721, 722, 723, 724]. Here, BDNF is linked to stroke disorder.